[HTML][HTML] Temporal Dynamics of Oxidative Stress and Inflammation in Bronchopulmonary Dysplasia

M Teng, TJ Wu, X Jing, BW Day, KA Pritchard Jr… - International Journal of …, 2024 - mdpi.com
Bronchopulmonary dysplasia (BPD) is the most common lung complication of prematurity.
Despite extensive research, our understanding of its pathophysiology remains limited, as …

[HTML][HTML] The Potential of Ambroxol as a Panacea for Neonatal Diseases: A Scoping Review

SY Al-Abdi, M Al-Aamri - Cureus, 2024 - pmc.ncbi.nlm.nih.gov
Ambroxol, a commonly used mucolytic agent, has been extensively studied for its clinical
effectiveness in managing respiratory conditions in pediatric and adult patients. The existing …

Impact of antenatal corticosteroids-to-delivery interval on very preterm neonatal outcomes: a retrospective study in two tertiary centers in Japan

K Fuma, T Kotani, H Tsuda, M Oshiro, S Tano… - BMC Pregnancy and …, 2024 - Springer
Background Antenatal corticosteroids (ACS) are administered to prevent neonatal
complications and death in women at risk of imminent preterm birth. Internationally, the …

A physiologically based toxicokinetic model of P-glycoprotein transporter-mediated placenta perfusion of dexamethasone in the pregnant rat

R Du, X Zhao, L Song, H Wang, D Liu… - Food and Chemical …, 2024 - Elsevier
The present dosage of Dexamethasone (DEX) administered to pregnant women may pose a
risk of toxicity to their unborn offspring. We aimed to develop a maternal-fetal physiologically …

Late Preterm Corticosteroids Exposure and Neurodevelopmental Outcomes

AC Vidaeff, E Asztalos - JAMA, 2024 - jamanetwork.com
In recent years, there has been a reevaluation of the upper gestational age limit
recommended for administration of antenatal corticosteroids. Seven randomized clinical …

Outcomes in Pregnancies Complicated with Preterm Hypertensive Disorders with and without Late Antenatal Corticosteroids

N Regev, M Axelrod, C Berkovitz… - American Journal of …, 2024 - thieme-connect.com
Objective This study aimed to determine whether administration of a late preterm (34–36
weeks) course of antenatal corticosteroids (ACS) is associated with improved short-term …